0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
110.57%
Revenue growth of 110.57% while ECL.AX is flat. Bruce Berkowitz would check if a small edge can widen further.
-58.43%
Negative gross profit growth while ECL.AX is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
61.64%
EBIT growth of 61.64% while ECL.AX is zero. Bruce Berkowitz would see if small gains can be scaled further.
61.64%
Operating income growth of 61.64% while ECL.AX is zero. Bruce Berkowitz would see if this modest edge can become significant.
100.00%
Net income growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
100.00%
EPS growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
50.00%
Diluted EPS growth of 50.00% while ECL.AX is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-4.41%
Share reduction while ECL.AX is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
6.04%
Diluted share change of 6.04% while ECL.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
100.00%
OCF growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
100.00%
FCF growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
No Data
No Data available this quarter, please select a different quarter.
368.71%
5Y revenue/share CAGR above 1.5x ECL.AX's 153.94%. David Dodd would look for consistent product or market expansions fueling outperformance.
229.13%
3Y revenue/share CAGR above 1.5x ECL.AX's 95.23%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
1067.01%
Positive OCF/share growth while ECL.AX is negative. John Neff might see a comparative advantage in operational cash viability.
653.23%
Positive 3Y OCF/share CAGR while ECL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
No Data
No Data available this quarter, please select a different quarter.
5933.00%
5Y net income/share CAGR above 1.5x ECL.AX's 114.71%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
110.45%
3Y net income/share CAGR 1.25-1.5x ECL.AX's 88.65%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
644.83%
5Y equity/share CAGR above 1.5x ECL.AX's 27.74%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
79.50%
3Y equity/share CAGR above 1.5x ECL.AX's 17.34%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Inventory is declining while ECL.AX stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.00%
Asset growth of 0.00% while ECL.AX is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
4.96%
BV/share growth of 4.96% while ECL.AX is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
9.21%
Debt shrinking faster vs. ECL.AX's 176.57%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-94.11%
We cut SG&A while ECL.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.